Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

A Gene Therapy Strategy To Restore Electrical And Cardiac Function In Arrhythmogenic Right Ventricular Cardiomyopathy


Technology Benefits

The invention provides and advantage over the current standard of care.


Technology Application

Gene therapy as a therapeutic treatment for ARVC.


Detailed Technology Description

Researchers at UC San Diego have developed a novel treatment strategy for ARVC by rescuing the cardiac electrical and physiological dysfunction associated with arrhythmogenic disorders and thereby potentially prolonging life. This strategy is based upon the use of a novel mouse model of ARVC and using gene therapy as a therapeutic to improve cardiac rhythm and function as demonstrated in our mouse model of ARVC by improving electrical, contractile, and potential survival.


Others

State Of Development

The current protocol has been developed in an ARVC mouse model.


Intellectual Property Info

A provisional patent has been submitted and the technology is available for licensing.


Tech ID/UC Case

29006/2018-065-0


Related Cases

2018-065-0


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View